Patients
Our Commitment to You
At AllRock Bio, patients are at the heart of everything we do. Our mission is to develop transformative therapies that improve lives, and we recognize that this journey is only possible through the courage and generosity of the people who participate in clinical research. We are deeply grateful to every patient, caregiver, and family member who walks this path with us.
Pulmonary Arterial Hypertension (PAH)
Pulmonary arterial hypertension (PAH) is a severe condition characterized by elevated blood pressure in the pulmonary arteries, impacting both the lungs and the right side of the heart. In PAH, the small pulmonary vessels undergo progressive narrowing, leading to elevated pulmonary arterial pressure. This heightened pressure impedes blood flow through the lungs, necessitating increased effort from the right ventricle to maintain adequate circulation, ultimately placing significant strain on the heart. Despite 16 approved drugs—including four vasodilator classes—there continues to exist an unmet need for disease-modifying treatments in the current landscape.
Pulmonary Hypertension associated with Interstitial Lung Disease (ILD-PH)
Pulmonary hypertension (PH) associated with Interstitial Lung Disease (ILD-PH) is a distinct form of PH where the blood pressure in the lungs increases in the setting of ILD. ILD encompasses a broad group of diseases, such as idiopathic pulmonary fibrosis, that impair the structure of the lungs, making it progressively harder to breathe. ILD-PH is associated with increased mortality and morbidity with worsening symptoms over time, and very limited treatment options are available.
Clinical Trials and Research
Participating in a clinical trial is a personal decision that requires time, commitment, and hope. We honor that choice by designing studies that prioritize patient safety, dignity, and access. Our current trial focuses on Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension with Interstitial Lung Disease (ILD-PH). We strive to make participation as seamless and supportive as possible.
ROCSTAR Study:
Learn more about our ongoing trial and eligibility criteria.
Contact Our Team:
If you have questions about participation, eligibility, or how to enroll, please reach out to our clinical team.